KRISTIN MADDOX: Open Payments
NPI 1639763956 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 37 payments from 14 companies in 2025. Trend: 2023 $568 · 2024 $584 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 9 | $213 |
| AstraZeneca Pharmaceuticals LP | 5 | $179 |
| Otsuka America Pharmaceutical, Inc. | 4 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Mallinckrodt Hospital Products Inc. | 2 | $57 |
| Calliditas Therapeutics US Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Ardelyx, Inc. | 2 | $36 |
| MERZ NORTH AMERICA, INC. | 1 | $33 |
| Apellis Pharmaceuticals, Inc. | 1 | $29 |
Products named: VELPHORO, Kerendia, TARPEYO, FARXIGA, IBSRELA, Xeomin, ACTHAR, Empaveli.
Industry payments across KY — which companies pay providers there.
